rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
1995-7-20
|
pubmed:abstractText |
Sendide is a selective and extremely potent antagonist of neurokinin-1 (NK1) receptors in the mouse spinal cord. The antinociceptive activities of sendide, an antagonist of NK1 receptors, and its analogue, [D-Trp7]sendide have been examined after intrathecal (i.t.) administrations in the mouse paw formalin test. Intrathecal administration of sendide (in pmol) reduced both the early and late phases of the formalin-induced licking response. [D-Trp7]sendide also produced a significant antinociceptive response with less potent activity than sendide. Even highest doses (4000 pmol sendide and 8000 pmol [D-Trp7]sendide) examined, there was no motor paralysis of the hindlimbs. Intrathecal morphine inhibited both the early and late phases of the formalin-induced licking response in a dose-dependent manner. The results indicate that the antinociceptive effects of sendide and [D-Trp7]sendide may be mediated at NK1 receptors in the formalin-induced nociception.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0304-3959
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
60
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
175-80
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:7540280-Animals,
pubmed-meshheading:7540280-Behavior, Animal,
pubmed-meshheading:7540280-Formaldehyde,
pubmed-meshheading:7540280-Injections, Spinal,
pubmed-meshheading:7540280-Male,
pubmed-meshheading:7540280-Mice,
pubmed-meshheading:7540280-Mice, Inbred Strains,
pubmed-meshheading:7540280-Pain,
pubmed-meshheading:7540280-Pain Measurement,
pubmed-meshheading:7540280-Peptide Fragments,
pubmed-meshheading:7540280-Pyrrolidonecarboxylic Acid,
pubmed-meshheading:7540280-Receptors, Neurokinin-1,
pubmed-meshheading:7540280-Substance P
|
pubmed:year |
1995
|
pubmed:articleTitle |
The neurokinin-1 receptor antagonist, sendide, exhibits antinociceptive activity in the formalin test.
|
pubmed:affiliation |
Department of Pharmacology, Tohoku College of Pharmacy, Sendai, Japan.
|
pubmed:publicationType |
Journal Article
|